S 927 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill gives funding starting in 2026 for the government to survey different types of pharmacies to find out the average prices of drugs covered by Medicaid, and pharmacies that don't take part in the surveys can be fined. It also pays for a government office to study the survey results and report back to Congress. Additionally, the bill changes how pharmacy benefit managers — companies that handle drug payments — are paid under Medicaid, requiring that the actual drug costs be passed through transparently and banning a practice called "spread pricing," where these companies charge more than what they pay pharmacies and keep the difference.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.